Consensus on Prostate Cancer Treatment of Localized Disease With Very Low, Low, and Intermediate Risk: A Report From the First Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).
Murilo de Almeida LuzGustavo Cardoso GuimarãesAguinaldo César NardiAlexandre Saad Feres Lima PompeoÁlvaro Sadek SarkisAmr NowierAntônio Carlos Lima PompeoArchimedes NardozzaAri AdamyArie CarneiroBernardo Peres SalvajoliBruno Santos BenignoCelso Heitor de FreitasClarissa Angotti Daher Cezar ChadeDaniel Moore Freitas PalharesDanilo Armando Citarella OteroDeusdedit Cortêz Vieira da Silva NetoEduardo Franco CarvalhalErlon GilFernando Freire de ArrudaFernando KorkesGustavo Caserta LemosGustavo Franco CarvalhalÍcaro Thiago de CarvalhoIvan Federico Pinto GimpelJosé Luis ChambôJosé PontesLeopoldo Alves Ribeiro FilhoLucas Mendes NogueiraMarcelo Langer WroclawskiMarcelo Roberto Pereira FreitasMarco Antônio ArapMarcus Vinicius SadiMuhammad BulbulRafael Ferreira CoelhoRafael GadiaRaja B KhauliRodolfo Borges Dos ReisRodrigo Antônio Ledezma RojasRoger Guilherme Rodrigues GuimarãesSaad A AldousariRobson FerrignoPublished in: JCO global oncology (2021)
The voting results and recommendations presented in this document can be used by physicians to support management for very low, low, and intermediate risk of PCa in areas of limited resources. Individual clinical decision making should be supported by available data; however, as guidelines for treatment for very low, low, and intermediate risk of PCa in developing countries have not been developed, this document will serve as a point of reference when confronted with this disease.